Literature DB >> 33855617

An appraisal of current service delivery and future models of care for young people with gender dysphoria.

Stephanie McCallion1, Simon Smith2, Heather Kyle1, M Guftar Shaikh1, Gordon Wilkinson2, Andreas Kyriakou3.   

Abstract

The clinical needs of young people with gender dysphoria (GD) have outpaced the capacity of health services to provide appropriate care. The study aimed to explore the interface of Paediatric Endocrinology and young people with GD, detailing the clinical characteristics and the clinical care provided, in order to inform future service development. Medical records of all young people with GD (n=91, 59 (65%) birth-assigned females and 32 (35%) birth-assigned males) referred to Paediatric Endocrinology during 2011-2019 for puberty suppression were reviewed. Median age at initial assessment was 14.6 years (range 8.8-17.6 years). There was a threefold increase from 2016 (n=22) to 2019 (n=73). Mental health disorders were present in 34 (37%) and autistic spectrum disorder in 21 (23%), while 54 (59%) had at least one comorbidity. Sixty-four (70%) young people fulfilled the criteria for consideration of fertility preservation, with 6 (9%) of them preserving their gametes. Seventy-nine (87%) young people commenced treatment with gonadotrophin-releasing hormone analogue, at a median age of 14.8 years (range 9.7-18.0 years). Six (8%) of those discontinued treatment, following a median duration of 6 months (range 6-18 months). Forty-one young people commenced gender-affirming hormones. One (2%) of those who started gender-affirming hormones discontinued treatment.Conclusions: We have witnessed increasing numbers of young people with GD attending Paediatric Endocrinology, with an over-representation of comorbidities, necessitating provision of an individualised approach to treatment. Addressing young people's acceptability of fertility services and ongoing close collaboration between endocrinology and mental health professionals require innovative models of multidisciplinary care. What is Known: • A worldwide increase in presentation of gender dysphoria has been mirrored in our service, with majority assigned female at birth and post-pubertal. • An over-representation of comorbidities exists, notably mental health disorders and autistic spectrum disorder. What is New: • Coordination of interprofessional care to meet complex needs, at an individual level, while improving efficiency of working, at a systemic level, can be met by the development of specialist centres. • The reasons for low uptake of fertility services demand further exploration.
© 2021. Crown.

Entities:  

Keywords:  Fertility preservation; Gender dysphoria; Gender-affirming hormones; GnRH analogue; Mental health; Specialist centres

Year:  2021        PMID: 33855617     DOI: 10.1007/s00431-021-04075-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent.

Authors:  P T Cohen-Kettenis; S H van Goozen
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-12       Impact factor: 4.785

2.  Perspectives on fertility preservation and parenthood among transgender youth and their parents.

Authors:  Lyne Noelle Chiniara; Christine Viner; Mark Palmert; Herbert Bonifacio
Journal:  Arch Dis Child       Date:  2019-03-20       Impact factor: 3.791

3.  Psychiatric disorders in individuals diagnosed with gender dysphoria: A systematic review.

Authors:  Larissa Dias de Freitas; Gabriela Léda-Rêgo; Severino Bezerra-Filho; Ângela Miranda-Scippa
Journal:  Psychiatry Clin Neurosci       Date:  2019-11-25       Impact factor: 5.188

4.  The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.

Authors:  Chantal M Wiepjes; Nienke M Nota; Christel J M de Blok; Maartje Klaver; Annelou L C de Vries; S Annelijn Wensing-Kruger; Renate T de Jongh; Mark-Bram Bouman; Thomas D Steensma; Peggy Cohen-Kettenis; Louis J G Gooren; Baudewijntje P C Kreukels; Martin den Heijer
Journal:  J Sex Med       Date:  2018-02-17       Impact factor: 3.802

Review 5.  Clinical management of gender dysphoria in children and adolescents: the Dutch approach.

Authors:  Annelou L C de Vries; Peggy T Cohen-Kettenis
Journal:  J Homosex       Date:  2012

6.  Mental Health of Transgender and Gender Nonconforming Youth Compared With Their Peers.

Authors:  Tracy A Becerra-Culqui; Yuan Liu; Rebecca Nash; Lee Cromwell; W Dana Flanders; Darios Getahun; Shawn V Giammattei; Enid M Hunkeler; Timothy L Lash; Andrea Millman; Virginia P Quinn; Brandi Robinson; Douglas Roblin; David E Sandberg; Michael J Silverberg; Vin Tangpricha; Michael Goodman
Journal:  Pediatrics       Date:  2018-04-16       Impact factor: 7.124

7.  Prevalence of Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder Amongst Individuals with Gender Dysphoria: A Systematic Review.

Authors:  Emily Thrower; Ingrid Bretherton; Ken C Pang; Jeffrey D Zajac; Ada S Cheung
Journal:  J Autism Dev Disord       Date:  2020-03

8.  CHILDREN AND ADOLESCENTS WITH GENDER DYSPHORIA IN ISRAEL: INCREASING REFERRAL AND FERTILITY PRESERVATION RATES.

Authors:  Anat Segev-Becker; Galit Israeli; Erella Elkon-Tamir; Liat Perl; Opal Sekler; Hadar Amir; Hagar Interator; Sharon Cohen Dayan; Efrat Chorna; Naomi Weintrob; Asaf Oren
Journal:  Endocr Pract       Date:  2020-02-11       Impact factor: 3.443

9.  Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study.

Authors:  Matthias K Auer; Johannes Fuss; Timo O Nieder; Peer Briken; Sarah V Biedermann; Günter K Stalla; Matthias W Beckmann; Thomas Hildebrandt
Journal:  J Sex Med       Date:  2018-05       Impact factor: 3.802

Review 10.  Current approach to the clinical care of adolescents with gender dysphoria.

Authors:  Andreas Kyriakou; Nicolas C Nicolaides; Nicos Skordis
Journal:  Acta Biomed       Date:  2020-03-19
View more
  2 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

2.  Continuous Renal Replacement Therapy for Hypertension Complicated by Refractory Heart Failure: An Analysis of Safety and Nursing Highlights.

Authors:  Miaoli Zhang; Jingfeng Li
Journal:  Comput Math Methods Med       Date:  2022-09-14       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.